Last checked at 9 Apr 2013 07:00
Hutchison China MediTech Limited ("Chi-Med")
(AIM: HCM)
2012 Annual Report and
Notice of Annual General Meeting
London: Tuesday, 9 April 2013: Chi-Med today announces that its 2012 Annual Report together with the Notice of Annual General Meeting and the Proxy Form have been posted to shareholders. The documents can be accessed from the website of Chi-Med (www.chi-med.com).
Ends
Enquiries
Chi-Med Christian Hogg, CEO | Telephone: +852 2121 8200
|
Panmure Gordon (UK) Limited | Telephone: +44 20 7886 2500 |
Richard Gray Andrew Potts Grishma Patel |
|
Citigate Dewe Rogerson Anthony Carlisle David Dible | Telephone: +44 20 7638 9571 Mobile: +44 7973 611 888 Mobile: +44 7967 566 919 |
About Chi-Med
Chi-Med is the holding company of a healthcare group based primarily in China and was listed on the Alternative Investment Market of the London Stock Exchange in May 2006. It is focused on researching, developing, manufacturing and selling pharmaceuticals and health oriented consumer products.
Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.